Dianicline/Rimonabant

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDianicline/Rimonabant
Drug Alias Name利莫那班/DianiclineDianicline and RimonabantRimonabant/DianiclineRimonabant and Dianicline
ClassificationSmall molecules
Mechanisms of ActionNeuronal acetylcholine receptor; alpha4/beta2 agonistsCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptorNeuronal acetylcholine receptor alpha4/beta2 complex
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes DianiclineRimonabant
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A